964 results on '"Van Poppel, Hein"'
Search Results
252. Radical prostatectomy in very high-risk localized prostate cancer: Long-term outcomes and outcome predictors
253. The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis
254. European Urological Association Lecture: Open Partial Nephrectomy--Tips and Tricks.
255. Lymph Node Dissection in Renal Cell Carcinoma
256. Treatment of Localised Renal Cell Carcinoma
257. The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance
258. 660 RRP AS STAND-ALONE THERAPY FOR HIGH-RISK PROSTATE CANCER
259. 707 DEVELOPMENT AND INTERNAL VALIDATION OF NOMOGRAMS PREDICTING PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS WITH HIGH RISK DISEASE. RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS
260. 291 IN HIGH-RISK PROSTATE CANCER, A PELVIC LYMPH NODE DISSECTION WITH >20 LYMPH NODES REMOVED AT RADICAL PROSTATECTOMY SIGNIFICANTLY IMPROVES OVERALL SURVIVAL
261. 469 ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY IN LOCALLY ADVANCED PROSTATE CANCER: A MULTI-CENTER EXPERIENCE
262. 1790 OUTCOME OF MULTIMODALITY TREATMENT OF VERY HIGH-RISK T4-PROSTATE CANCER WITH RADICAL CYSTECTOMY AS INITIAL STEP
263. 699 THE PROGNOSTIC SIGNIFICANCE OF TUMOR DIAMETER IN INCIDENTALLY DETECTED SMALL RENAL MASSES
264. 706 ADJUVANT RADIOTHERAPY LEADS TO SUPERIOR BIOCHEMICAL RECURRENCE FREE SURVIVAL COMPARED TO EARLY SALVAGE RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER: RESULTS OF A MATCHED-CONTROLLED MULTI-INSTITUTIONAL ANALYSIS
265. 1474 PT3-PROSTATE CANCER-POSITIVE SURGICAL MARGIN AT BLADDER NECK IS AN INDEPENDANT PREDICTOR OF LOCAL FAILURE AND PROSTATE CANCER MORTALITY: RESULTS OF A PROSPECTIVE SINGLE INSTITUTION SERIES
266. 1630 MICRO-RNA-221 IS A STRONG AND INDEPENDENT PREDICTOR OF CLINICAL PROGRESSION AND CSS IN HIGH-RISK PROSTATE CANCER
267. 294 IN HIGH-RISK PROSTATE CANCER, 3 OR MORE POSITIVE NODES AT RADICAL PROSTATECTOMY REPRESENT AN INDEPENDENT PREDICTOR OF WORSE CSS, WHILE 1 OR 2 POSITIVE NODES DO NOT INFLUENCE CSS
268. 471 THE NUMBER OF POSITIVE SECTION MARGINS IN HIGH-RISK PROSTATE CANCER IS A POWERFUL AND INDEPENDENT PREDICTOR OF CANCER-SPECIFIC AND OVERALL SURVIVAL IN HIGH-RISK LOCALIZED PROSTATE CANCER
269. Metabolic Changes after Urinary Diversion
270. Lymph node dissection is not obsolete in clinically node-negative Renal Cell Carcinoma patients
271. “LuproCare”: A patient support programme to improve quality of life in patients with prostate cancer treated with LHRH agonists
272. Reply to Endre Zoltan Neulander and Zev Wejsman’s Letter to the Editor re: Martin Spahn, Steven Joniau, Paolo Gontero, et al. Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients. Eur Urol 2010;58:1–7
273. Reply from Authors re: Leah Gerber, Lionel L. Bañez, Stephen J. Freeland. Defining and Treating High-Risk Prostate Cancer: Can We Do Better? Eur Urol 2010;58:8–9
274. An improved orthotopic rat bladder tumor model using DiI-loaded fluorescent AY-27 cells
275. 2030 HIGH-RISK PROSTATE CANCER PATIENTS WHO HAVE SPECIMEN-CONFINED DISEASE AT PATHOLOGY HAVE EXCEPTIONALLY GOOD OUTCOMES AFTER SURGERY
276. 1063 TIME TO BIOCHEMICAL RECURRENCE IS A STRONG AND INDEPENDENT PREDICTOR OF CSS AND OS IN HIGH-RISK PROSTATE CANCER
277. 1061 VALUE OF ELND IN LYMPH NODE NEGATIVE PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER IS UNCERTAIN
278. 578 PREDICTING PROSTATE CANCER SPECIFIC OUTCOME AFTER RADICAL PROSTATECTOMY AMONG MEN WITH PSA &[GE] 20 NG/ML WITH OR WITHOUT ADDITIONAL HIGH RISK FACTORS: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 712 PATIENTS
279. Prognostic factors for and outcome of locally advanced prostate cancer after radical prostatectomy
280. A patient support programme to improve quality of life in patients with prostate cancer treated with LH-RH agonists
281. Is Radiotherapy Useful in Node-Positive Prostate Cancer Patients after Radical Prostatectomy?
282. OUTCOME OF MULTIMODALITY TREATMENT OF HIGH-RISK LOCALIZED PROSTATE CANCER (CT3-4 OR PSA ≥20 NG/ML OR BIOPSY GLEASON SCORE ≥8) WITH RADICAL PROSTATECTOMY AS INITIAL STEP: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 1413 PATIENTS
283. RADICAL PROSTATECTOMY IN VERY HIGH RISK LOCALIZED PROSTATE CANCER
284. OUTCOME OF MULTIMODALITY TREATMENT WITH RADICAL PROSTATECTOMY AS INITIAL STEP FOR PROSTATE CANCER WITH PSA >20 NG/ML : A MULTI-INSTITUTIONAL OUTCOME STUDY OF 801 PATIENTS
285. EORTC-GU group expert opinion on metastatic renal cell cancer
286. Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881
287. Different Angiogenic Potential in Low and High Grade Sporadic Clear Cell Renal Cell Carcinoma Is Not Related to Alterations in the von Hippel–Lindau Gene
288. Prepubic urethrectomy
289. Re: Long-Term Outcome Following Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy for Clinical Stage T3 Prostate Cancer
290. Neoadjuvant and Adjuvant Hormone Therapy: How and When?
291. Is nephron-sparing surgery as safe and effective as radical nephrectomy in patients with locally advanced RCC?
292. Splitting and Lumping Adult Renal Epithelial Tumors Can Help the Urologists in the Prognostic Risk Stratification and in the Treatment Decision-Making
293. QUALITY CONTROL IN NERVE-SPARING RADICAL RETROPUBIC PROSTATECTOMY – RESULTS OF THE EUROPEAN SOCIETY OF ONCOLOGICAL UROLOGY (ESOU)
294. CLINICAL T3 PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: RESULTS FROM THE EUROPEAN SOCIETY OF ONCOLOGICAL UROLOGY (ESOU)
295. Localized prostate cancer: can we better define who is at risk of unfavourable outcome?
296. Salvage reconstructive surgery in an adult patient with failed previous repair of an extrophy-epispadias complex: an operation with a functional and aesthetic purpose
297. Reply to Apostolos P. Labanaris et al's Letter to the Editor re: Ziya Kirkali and Hein Van Poppel. A Critical Analysis of Surgery for Kidney Cancer with Vena Cava Invasion. Eur Urol 2007;52:658–62
298. Analysis of renal cell carcinoma with subdiaphragmatic macroscopic venous invasion (T3b)
299. Should the pT2 tumor classification for renal cell carcinoma be subdivided according to tumor size?
300. Efficacy and Safety of TachoSil ® as Haemostatic Treatment versus Standard Suturing in Kidney Tumour Resection: A Randomised Prospective Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.